Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Acetyl-L-Carnitine for the Treatment of NRTI-Associated Peripheral Neuropathy
This study has been completed.
Study NCT00050271 Information provided by National Institute of Allergy and Infectious Diseases (NIAID)
First Received: December 3, 2002 Last Updated: June 24, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
HIV Infections
Peripheral Nervous System Diseases
Additional conditions recognized in this trial
Acquired Immunodeficiency Syndrome
Infection
Nervous System Diseases
More general conditions related to this trial
Immune System Diseases
Immunologic Deficiency Syndromes
Lentivirus Infections
Neuromuscular Diseases
Retroviridae Infections
RNA Virus Infections
Sexually Transmitted Diseases
Sexually Transmitted Diseases, Viral
Slow Virus Diseases
Virus Diseases
Interventions listed in this trial
Acetyl-L-carnitine
Additional drug interventions recognized in this trial
Acetylcarnitine
Carnitine
Dideoxynucleosides
More general drug interventions related to this trial
Anti-Infective Agents
Anti-Retroviral Agents
Antimetabolites
Antiviral Agents
Central Nervous System Agents
Enzyme Inhibitors
Growth Substances
Micronutrients
Molecular Mechanisms of Pharmacological Action
Nootropic Agents
Nucleic Acid Synthesis Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Reverse Transcriptase Inhibitors
Therapeutic Uses
Vitamin B Complex
Vitamins
Sponsors listed in this trial
National Institute of Allergy and Infectious Diseases (NIAID)
Neurologic AIDS Research Consortium (NARC)
Back to top of Main Content
